PATENT CLAIM ANALYSIS

Application Number: 15768025
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.

Claim (Index 5):
Compounds for the use according to any one of the preceding claims, wherein Ar is an optionally substituted bicyclic heteroaryl, forming compounds according to formula (IVd) wherein the bicyclic heteroaryl ring may carry 1 to 3 substituents, preferably 1 or 2 substituents; and wherein the bicyclic heteroaryl ring may be fused with a ring formed by R 3  and A 2  together with the nitrogen atom to which they are bonded, and wherein R 1 , R 2 , Z, R 3 , A 1  and A 2  have the meaning as defined in the preceding claims.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.25532
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15769148', '14310254', '15517528', '14007533', '15185186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7877707955747695
- 35 USC 102 Novelty (BERT): 0.5566534916322814
- Combined Prediction Score: 0.7646590651805207
- Mean Citation Score: 298.633386
- Max Citation Score: 422.5474
- Similarity Product: 363.412580936718

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test